Oncology

Latest News

Top 5 Most-Read Oncology Content of 2024

December 25th 2024

This year’s most-read oncology content of 2024 includes topics on clinical trials, drug access, vaping and lung cancer, and more!

Most Popular Articles of 2024 in Evidence-Based Oncology

By Mary Caffrey

December 23rd 2024

ICYMI: Highlights From ASCO 2024

By Pearl Steinzor

December 21st 2024

chemotherapy | Image credit: Penn Medicine

The High Cost of Shortages of Low-Cost Chemotherapy

By Interview by Mary Caffrey

December 19th 2024

Leukemia diagnosis | Image credit: Vitalii Vodolazskyi - stock.adobe.com

Real-World Treatment Sequences and Cost Analysis of cBTKis in CLL

By Pearl Steinzor

December 17th 2024

Join this panel as they discuss treatment for metastatic NSCLC patients without driver mutations.

Watch the series now!

Watch Now

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

October 27th 2015

Confusion Reigns in Wake of Study Linking Processed Meat to Cancer

Mary K. Caffrey

A study shows too much conflicting dietary advice causes some people to tune it all out. Nuances in the report from WHO are lost on most consumers.

October 27th 2015

Amgen's T-Vec to Receive FDA Decision Today

AJMC Staff

The vaccine, approved in Europe last week, is now awaiting approval in the United States.

October 26th 2015

Beyond the Disease: the Economic Hardships of Cancer

Surabhi Dangi-Garimella, PhD

A study published in the journal Cancer presents the financial impact of cancer on a survivor and his family.

October 24th 2015

This Week in Managed Care: October 24, 2015

This week in managed care, documents show Horizon Blue Cross Blue Shield of NJ rolled out OMNIA prior to receiving regulatory approval, 2 Harvard professors argue the merit of the annual physical, and experts weigh in on the successes and flaws of Medicare Part D.

October 23rd 2015

Amgen's First-in-Class Viral Drug, T-Vec, Could Soon Be Approved by EMA

AJMC Staff

The drug is awaiting an FDA verdict next week.

October 23rd 2015

5 Things to Know About 340B

Surabhi Dangi-Garimella, PhD

As the date for the comment period on the proposed guidance by HHS on 340B drug pricing draws near, read about the program and its impact on healthcare overall.

October 23rd 2015

Harvard Researchers Identify Racial Disparity in Care of Cancer Patients on Medicare

Surabhi Dangi-Garimella, PhD

Published in JAMA Oncology, the study found a significant difference in quality and access to care for black patients diagnosed with localized prostate cancer.

October 22nd 2015

Urology Cancer Patients Faced Neglect at Arizona VA Hospital

Surabhi Dangi-Garimella, PhD

Patients with cancer in the urology clinic at a VA hospital in Arizona may have suffered adverse outcomes due to clinical disconnect and staff shortage.

October 22nd 2015

Onivyde Approved for Advanced Pancreatic Cancer

AJMC Staff

Patients with metastatic pancreatic cancer who have progressed on gemcitabine now have the option of Onivyde combined with leucovorin/fluorouracil.

October 22nd 2015

ERLS Improves Functional Status Post Oncologic Liver Surgery

Surabhi Dangi-Garimella, PhD

A study published in the Journal of the American College of Surgeons found that including patients in the Enhanced Recovery program has a dramatic impact on their recovery post surgery.

October 21st 2015

LIVESTRONG Fertility Training Helping Empowers Healthcare Professionals With Tools for Cancer Care

Earlier this year, the LIVESTRONG Foundation launched a project to fill a critical gap in cancer care: training healthcare professionals to offer fertility services for adolescent and young adult patients. A new commentary in Evidence-Based Oncology discusses the barriers to fertility training and why is essential to overcome them.

October 21st 2015

The Benefit of Marrying PROs With Coordinated Care in Advanced Cancer Patients

Surabhi Dangi-Garimella, PhD

A presentation at the annual meeting of the American Society for Radiation Oncology underscored the importance of patient-centered care and the benefit of incorporating the patient voice in advanced oncology care.

October 21st 2015

Dr Laura Long Outlines the Difficulty of Measuring Quality of Life

Measuring quality of life in oncology care is difficult for a number of reasons, but Laura Long, MD, MPH, president at TheLongView, PC, expects that to change in the future.

October 21st 2015

Do Surrogate Endpoints Fail the Litmus Test?

Surabhi Dangi-Garimella, PhD

A letter published in JAMA Internal Medicine questions the FDA's acceptance of surrogate endpoints for what the authors describe as "costly, toxic drugs that do not improve overall survival."

October 20th 2015

American Cancer Society Now Recommends Delayed and Less Frequent Screening Mammograms

Surabhi Dangi-Garimella, PhD

A new evidence-based guidance update provided by the American Cancer Society, published yesterday in JAMA Internal Medicine, recommends a delay in initiating screening mammograms in women with an average risk of developing the disease.

October 19th 2015

Lower-Income Cancer Patients Less Likely to Participate in Clinical Trials

Jackie Syrop

A recent study finds that newly diagnosed cancer patients with incomes below $50,000 are less likely to participate in clinical trials than patients with higher incomes, providing more evidence that income disparities in trial participation remains a serious problem.

October 19th 2015

Ensuring Education for Stakeholders of Personalized Medicine

Surabhi Dangi-Garimella, PhD

A panel discussion at the PMC/BIO Solutions Summit in Washington, DC, saw an exchange on widespread and appropriate education of personalized medicine among payers, providers, patients, and families.

October 18th 2015

Dr Veena Shankaran Examines Financial Burdens Facing Cancer Patients

There are a number of financial hardships patients with cancer can face, even if they are insured, such as loss of employment, depletion of retirement accounts, and bankruptcy, said Veena Shankaran, MD, MS.

October 17th 2015

This Week in Managed Care: October 17, 2015

Top managed care stories this week include comparing US healthcare spending and outcomes to other wealthy nations, identifying how many Americans are affected by Medicaid expansion coverage gaps, and a look at adolescents and young patients with cancer.

October 16th 2015

NCCN Unveils Value Tool for CML and MM

AJMC Staff

NCCN Evidence Blocks add affordability to Guidelines recommendations on safety, efficacy, quality, and consistency of regimens.

October 16th 2015

Antibiotic Resistance Can Negate the Value of Surgery and Cancer Immunotherapy

Surabhi Dangi-Garimella, PhD

The results of a study published in The Lancet Infectious Diseases necessitate a wake-up call for stakeholders to develop a new approach that can overcome the rapidly-growing threat of antibiotic resistance.

October 16th 2015

Rapid Innovation in Medical Diagnostics a Major Challenge for Payers

Surabhi Dangi-Garimella, PhD

Not just providers of care, but payers as well have been having a hard time embracing the rapidly-evolving and dynamic field of personalized medicine, according to panel members at the recently held PMC/BIO Solutions Summit.

October 15th 2015

Health Plan Recommends More Interventions for Tangible Results With Choosing Wisely

Surabhi Dangi-Garimella, PhD

The analysis by Anthem Inc, has identified a need for more widespread implementation of these interventions aimed at reducing healthcare utilization.

October 15th 2015

Study Confirms: Calcium and Vitamin D Cannot Prevent Colon Cancer

Surabhi Dangi-Garimella, PhD

The study, published in the New England Journal of Medicine failed to confirm epidemiologic and preclinical data that vitamin D and calcium can reduce the risk of colorectal neoplasia.

October 15th 2015

Mary Lou Smith on Ensuring Patients Feel Cared For

One way to make all patients with cancer, regardless of socioeconomic status, feel like they're on the same level when receiving treatment is to ensure they know they're being taken care of, said Mary Lou Smith, MBA, co-founder of the Research Advocacy Network.

October 15th 2015

Organization That Addresses "Financial Toxicity" in Young Cancer Survivors Featured in Evidence-Based Oncology

The Samfund, the first and largest group created to help young adults address the costs of cancer, is featured in the current issue of Evidence-Based Oncology, a publication of The American Journal of Managed Care. Samfund officers Samantha Watson, MBA, and Michelle S. Landwehr, MPH, address the challenges of "financial toxicity" for young adult survivors.

October 15th 2015

Patient Advocacy Meets Payer in the World of Personalized Medicine

Surabhi Dangi-Garimella, PhD

A panel discussion during the 2nd PMC/BIO Solutions Summit identified barriers and discussed the path forward to improve clinical integration of precision medicine.

October 14th 2015

Financial Toxicity and the Young Adult Cancer Survivor

Samantha Watson, MBA Michelle S. Landwehr, MPH

The financial aftereffects of cancer have a tremendous impact on young adults as they move forward with their lives after treatment.

October 14th 2015

FDA Updates in Oncology

Surabhi Dangi-Garimella, PhD

Updates on FDA approvals and extended indications for oncology drugs.

October 14th 2015

Using a Gene Expression Assay to Predict Response to NAC in Breast Cancer

Surabhi Dangi-Garimella, PhD

Evaluation of Prosigna's risk of relapse score as a predictor of response to multiagent neoadjuvant chemotherapy in HR+/HER2 breast cancer patients.

...

114 115 116 117 118 119 120 121 122

...

181 >

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions